The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bubnova I.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Egorova G.B.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Mitichkina T.S.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Averich V.V.

Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021

Fettser E.I.

Research Institute of Eye Diseases, 11 A, B Rossolimo St., Moscow, Russian Federation, 119021

Secondary dry eye syndrome after keratorefractive surgeries and approaches to its treatment and prevention

Authors:

Bubnova I.A., Egorova G.B., Mitichkina T.S., Averich V.V., Fettser E.I.

More about the authors

Journal: Russian Annals of Ophthalmology. 2018;134(5): 294‑298

DOI: 10.17116/oftalma2018134051294

Read: 3309 times

Download PDF (RU)
Contact the author
Table of contents

SECONDARY DRY EYE SYNDROME AFTER KERATOREFRACTIVE SURGERIES AND APPROACHES TO ITS TREATMENT AND PREVENTION
SECONDARY DRY EYE SYNDROME AFTER KERATOREFRACTIVE SURGERIES AND APPROACHES TO ITS TREATMENT AND PREVENTION

To cite this article:

Bubnova IA, Egorova GB, Mitichkina TS, Averich VV, Fettser EI. Secondary dry eye syndrome after keratorefractive surgeries and approaches to its treatment and prevention. Russian Annals of Ophthalmology. 2018;134(5):294‑298. (In Russ.)
https://doi.org/10.17116/oftalma2018134051294

Подписка 2026 Вестник офтальмологии (Russian Annals of Ophthalmology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diffuse lame­llar kera­titis: sporadic and cluster forms. Russian Annals of Ophthalmology. 2025;(4):34-40
Abstract:

The article reviews the particularities of development and pathogenesis of secondary dry eye syndrome (DES) after refractive surgeries including a complex of problems related to changes in tear film content, damage of eye surface and neurotrophic epitheliopathy. Additionally, modern algorithms of treatment and prevention of secondary DES in patients after refractive surgeries are described. Despite the transient nature of the changes, excimer-laser surgery can lead to lasting deficiencies of eye surface in some patients. Therefore, intensive and early treatment of secondary DES during the early follow-up period after refractive surgery may significantly reduce risks of tear dysfunction and neurotrophic epitheliopathy development in the long term.

Keywords:

secondary dry eye syndrome
refractive surgery
artificial tears
cationorm

Authors:

Bubnova I.A.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Egorova G.B.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Mitichkina T.S.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Averich V.V.

Research Institute of Eye Diseases, 11A Rossolimo St., Moscow, Russian Federation, 119021

Fettser E.I.

Research Institute of Eye Diseases, 11 A, B Rossolimo St., Moscow, Russian Federation, 119021

Close metadata

References:

  1. Duffey RJ, Leaming D. US trends in refractive surgery: 2004 ISRS/AAO Survey. Journal of Refractive Surgery. 2005;21(6):742-748.
  2. Solomon KD, de Castro LEF, Sandoval HP, Biber JM, Groat B, Neff KD, et al. LASIK world literature review: quality of life and patient satisfaction. Ophthalmology. 2009;116(4):691-701. https://doi.org/10.1016/j.ophtha.2008.12.037
  3. Toda I. LASIK and the ocular surface. Cornea. 2008;27:70-76. https://doi.org/10.1097/ICO.0b013e31817f42c0
  4. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Experimental Eye Research. 2004;78(3):409-416.
  5. Rah MJ. A review of hyaluronan and its ophthalmic applications. Optometry-Journal of the American Optometric Association. 2011;82(1):38-43.
  6. Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo C-K, et al. TFOS DEWS II definition and classification report. The Ocular Surface. 2017;15(3):276-283.
  7. Egorov AE, Romanova TB, Rybakova EV, Oganezova GG. Modern approaches to prophylaxis and treatment of artificial «dry eye» syndrome. RMJ Klinicheskaya oftalmologia. 2017;18(1):61-64. (In Russ.)
  8. Wilson SE, Ambrósio R. Laser in situ keratomileusis-induced neurotrophic epitheliopathy. American Journal of Ophthalmology. 2001;132(3):405-406.
  9. Wilson SE. Laser in situ keratomileusis—induced (presumed) neurotrophic epitheliopathy. Ophthalmology. 2001;108(6):1082-1087.
  10. Rodriguez-Prats JL, Hamdi IM, Rodriguez AE, Galal A, Alio JL. Effect of suction ring application during LASIK on goblet cell density. Journal of Refractive Surgery. 2007;23(6):559-562.
  11. Albietz JM, Lenton LM, McLennan SG. Effect of laser in situ keratomileusis for hyperopia on tear film and ocular surface. Journal of Refractive Surgery. 2002;18(2):113-123.
  12. Albietz J, Lenton L, McLennan S. The effect of ocular surface management on myopic LASIK outcomes. Cornea. 2000;19(6):73.
  13. Denoyer A, Landman E, Trinh L, Faure J-F, Auclin F, Baudouin C. Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK. Ophthalmology. 2015;122(4):669-676. https://doi.org/10.1016/j.ophtha.2014.10.004
  14. Mian SI, Shtein RM, Nelson A, Musch DC. Effect of hinge position on corneal sensation and dry eye after laser in situ keratomileusis using a femtosecond laser. Journal of Cataract & Refractive Surgery. 2007;33(7):1190-1194.
  15. Salomão MQ, Ambrósio JrR, Wilson SE. Dry eye associated with laser in situ keratomileusis: mechanical microkeratome versus femtosecond laser. Journal of Cataract & Refractive Surgery. 2009;35(10):1756-1760. https://doi.org/10.1016/j.jcrs.2009.05.032
  16. Barequet IS, Levinger S, Hirsh A. Effect of thin femtosecond LASIK flaps on corneal sensitivity and tear function. Journal of Refractive Surgery. 2008;24(9):897-902.
  17. Kumano Y, Matsui H, Zushi I, Mawatari A, Matsui T, Nishida T, et al. Recovery of corneal sensation after myopic correction by laser in situ keratomileusis with a nasal or superior hinge1. Journal of Cataract & Refractive Surgery. 2003;29(4):757-761.
  18. Benitez-del-Castillo JM, del Rio T, Iradier T, Hernández JL, Castillo A, Garcia-Sanchez J. Decrease in tear secretion and corneal sensitivity after laser in situ keratomileusis. Cornea. 2001;20(1):30-32.
  19. Gallar J, Acosta MC, Moilanen JA, Holopainen JM, Belmonte C, Tervo TM. Recovery of corneal sensitivity to mechanical and chemical stimulation after laser in situ keratomileusis. Journal of Refractive Surgery. 2004;20(3):229-235.
  20. Kim W-S, Kim J-S. Change in corneal sensitivityfollowing laser in situ keratomileusis. Journal of Cataract & Refractive Surgery. 1999;25(3):368-373.
  21. Battat L, Macri A, Dursun D, Pflugfelder SC. Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface. Ophthalmology. 2001;108(7):1230-1235.
  22. Erie JC, McLaren JW, Hodge DO, Bourne WM. Recovery of corneal subbasal nerve density after PRK and LASIK. American Journal of Ophthalmology. 2005;140(6):1059-1064.e1. https://doi.org/10.1016/j.ajo.2005.07.027
  23. Lee SJ, Kim JK, Seo KY, Kim EK, Lee HK. Comparison of corneal nerve regeneration and sensitivity between LASIK and laser epithelial keratomileusis (LASEK). American Journal of Ophthalmology. 2006;141(6):1009-1015.e1.
  24. Lee BH, McLaren JW, Erie JC, Hodge DO, Bourne WM. Reinnervation in the cornea after LASIK. Investigative Ophthalmology & Visual Science. 2002;43(12):3660-3664.
  25. Darwish T, Brahma A, Efron N. Subbasal nerve regeneration after LASEK measured by confocal microscopy. Journal of Refractive Surgery. 2007;23(7):709-715.
  26. Moilanen JA, Holopainen JM, Vesaluoma MH, Tervo TM. Corneal recovery after LASIK for high myopia A 2-year prospective confocal microscopic study. British Journal of Ophthalmology. 2008;92(10):1397-1402. https://doi.org/10.1136/bjo.2007.126821
  27. Calvillo MP, McLaren JW, Hodge DO, Bourne WM. Corneal reinnervation after LASIK: prospective 3-year longitudinal study. Investigative Ophthalmology & Visual Science. 2004;45(11):3991-3996. https://doi.org/10.1167/iovs.04-0561
  28. Vestergaard AH, Grønbech KT, Grauslund J, Ivarsen AR, Hjortdal JØ. Subbasal nerve morphology, corneal sensation, and tear film evaluation after refractive femtosecond laser lenticule extraction. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2013;251(11):2591-2600. https://doi.org/10.1007/s00417-013-2400-x
  29. De Paiva CS, Chen Z, Koch DD, Hamill MB, Manuel FK, Hassan SS, et al. The incidence and risk factors for developing dry eye after myopic LASIK. American Journal of Ophthalmology. 2006;141(3):438-445. https://doi.org/10.1016/j.ajo.2005.10.006
  30. Toda I, Asano-Kato N, Komai-Hori Y, Tsubota K. Dry eye after laser in situ keratomileusis. American Journal of Ophthalmology. 2001;132(1):1-7.
  31. Shoja M, Besharati M. Dry eye after LASIK for myopia: incidence and risk factors. European Journal of Ophthalmology. 2007;17(1):1-6.
  32. Nettune GR, Pflugfelder SC. Post-LASIK tear dysfunction and dysesthesia. The Ocular Surface. 2010;8(3):135.
  33. Shtein RM. Post-LASIK dry eye. Expert Review of Ophthalmology. 2011;6(5):575-582. https://doi.org/10.1586/eop.11.56
  34. Lee JB, Ryu CH, Kim J-H, Kim EK, Kim HB. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis1. Journal of Cataract & Refractive Surgery. 2000;26(9):1326-1331.
  35. Egorov EA, Romanova TB, Rybakova EV, Oganezova GG. Artificial «dry eye» syndrome: modern opinion of problem. RMJ Klinicheskaya oftalmologia. 2017;18(2):106-110. (In Russ.)
  36. Brzheskiy VV. Algorithm of selecting the tear replacement therapy in ambulatory practice. RMJ Klinicheskaya oftalmologia. 2018;(1):13-19. (In Russ.)
  37. Egorov EA. Dry eye syndrome, associated with the wearing of contact lenses. Features of the therapeutic approach. RMJ Klinicheskaya oftalmologia. 2018;2:66-69. (In Russ.)
  38. Kirwan C. Postoperative pain following epi-LASIK, LASEK, and PRK for myopia. Journal of Refractive Surgery. 2007;23(2):133-138.
  39. Levitt AE, Galor A, Weiss JS, Felix ER, Martin ER, Patin DJ, et al. Chronic dry eye symptoms after LASIK: parallels and lessons to be learned from other persistent post-operative pain disorders. Molecular Pain. 2015;11(1):21.
  40. Ambrósio JrR, Tervo T, Wilson SE. LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. Journal of Refractive Surgery. 2008;24(4):396-407.
  41. Clouzeau C, Godefroy D, Riancho L, Rostène W, Baudouin C, Brignole-Baudouin F. Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro. Molecular Vision. 2012;18:851.
  42. Kalyvianaki MI, Katsanevaki VJ, Kavroulaki DS, Kounis GA, Detorakis ET, Pallikaris IG. Comparison of corneal sensitivity and tear function following Epi-LASIK or laser in situ keratomileusis for myopia. American Journal of Ophthalmology. 2006;142(4):669-671. https://doi.org/10.1016/j.ajo.2006.04.054
  43. Egorov EA. Hyaluronic acid: application in ophthalmology and therapy of «dry eye» syndrome. RMJ Klinicheskaya Oftalmologia. 2013;2:71-73. (In Russ.)
  44. Rybakova EG, Egorova GB, Kalinich NI. Korneregel is a new stimulator of reparative regeneration. Oftalmologia vostochnaya evropa. 2009;3:63-66. (In Russ.)
  45. Orobia AJM, Saa J, Lorenzo AO, Herreras JM. Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease. Clinical Ophthalmology (Auckland, NZ). 2018;12:453.
  46. Egorov AE, Egorova GB. A new medication of artificial tear with prolonged action Oftagel for correction dry eye syndrom. RMJ Klinicheskaya oftalmologia. 2001;2(3):123-124. (In Russ.)
  47. Maichuk YuF, Yani EV. Study of efficacy of Ophtolique medication application in «dry eye» syndrome. RMJ Klinicheskaya oftalmologia. 2009;1:33-36. (In Russ.)
  48. Yao K, Bao Y, Ye J, Lu Y, Bi H, Tang X, et al. Efficacy of 1% carboxymethylcellulose sodium for treating dry eye after phacoemulsification: results from a multicenter, open-label, randomized, controlled study. BMC Ophthalmo- logy. 2015;15(1):28. https://doi.org/10.1186/s12886-015-0005-3
  49. Kogan G, Šoltés L, Stern R, Gemeiner P. Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications. Biotechnology Letters. 2007;29(1):17-25. https://doi.org/10.1007/s10529-006-9219-z
  50. Brzheskiy VV, Golubev SYu. Potential for use of hydroxypropyl guar in tear substitute therapy. Vestnik oftal’mologii. 2017;133(1):88-96. (In Russ.) https://doi.org/ 10.17116/oftalma2017133188-96
  51. Vokhmyakov AV. The evolution of tear substitutes: from saline solutions to cationic nanoemulsion. Oftalmologicheskie vedomosti. 2014;7(1):41-46. (In Russ.)
  52. Benelli U. Systane lubricant eye drops in the management of ocular dryness. Clinical Ophthalmology (Auckland, NZ). 2011;5:783.
  53. Brzhesky VV. Dry eye syndrome: a disease of the civilization. diagnosis and treatment options. Medicinskyi sovet. 2013;3:114-116. (In Russ.)
  54. Egorov EA, Romanova TB, Kac DV, Bordashevskaya LS, Oleynik AI, Ilyasova IV. Application of Hylo Parin Comod solution in ophthalmological practice (pilot research). RMJ Klinicheskaya oftalmologia. 2014;4:207-212. (In Russ.)
  55. Egorova GB, Fyodorov AA, Mitichkina TS, Shamsudinova AR, Safonova TN. Influence of tear substitute and corneal propection therapy on condition of eye surface at «dry eye» syndrome. RMJ Klinicheskaya oftalmologia. 2015;1:15-21. (In Russ.)
  56. Lallemand F, Daull P, Benita S, Buggage R, Garrigue J. Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. Journal of Drug Delivery. 2012;2012:1-16. https://doi.org/10.1155/2012/604204
  57. Lyseng-Williamson KA. Cationorm (cationic emulsion eye drops) in dry eye disease: a guide to its use. Drugs & Therapy Perspectives. 2016;32(8):317-322.
  58. Daull P, Lallemand F, Garrigue JS. Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. Journal of Pharmacy and Pharmacology. 2014;66(4):531-541. https://doi.org/10.1111/jphp.12075
  59. Quentric Y, Daull P, Gros E, Antonelli S, Mauro V, Feraille L, et al. Safety evaluation of cationic emulsions following refractive surgery procedures. Investigative Ophthalmology & Visual Science. 2017;58(8):5297.
  60. Aragona P, Papa V, Micali A, Santocono M, Milazzo G. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. British Journal of Ophthalmology. 2002;86(2):181-184.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.